Correction to “High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles”
Abstract
[This corrects the article DOI: 10.1021/acscentsci.8b00746.].
Fields of Study & Subjects
Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Radiopharmaceutical Chemistry and Applications
Publication details
- Journal / source
- ACS Central Science
- Volume
- 12
- Issue
- 3
- Pages
- 383–383
- Publication date
- 10 February 2026
- Language
- EN